Monday, 12 June 2023 The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.
TODAY ON THE ROBERT SCOTT BELL SHOW: Vaccine debate paradigm, Vax legislation stalled, Jeff Pearson, Hydrocephalus, Danny Bonaduce surgery, Glyphosate safe levels, ADHD medication warning, Psychotic..